首页> 外文期刊>Journal of biomedical materials research, Part A >Study of the electrospun PLA/silk fibroin-gelatin composite nanofibrous scaffold for tissue engineering
【24h】

Study of the electrospun PLA/silk fibroin-gelatin composite nanofibrous scaffold for tissue engineering

机译:用于组织工程的电纺PLA /丝素蛋白-明胶复合纳米纤维支架的研究

获取原文
获取原文并翻译 | 示例
           

摘要

In this article, a nanofibrous composite scaffold of poly L-lactic acid(PLA)/silk fibroin(SF)-gelatin was fabricated by multilayer electrospinning. To investigate the feasibility of PLA/SF-gelatin use as scaffolds, the porosity and mechanical properties were examined; in particular, the biocompatibilities were evaluated in vivo and in vitro by the means of cell adhesion and cytotoxicity testing, short-term subcutaneous implantation testing, and acute hemolysis testing according to the requirements of ISO 10993. The results showed the scaffold achieved the desirable levels of pliability (elastic up to 7.3% strain) and the appropriate breaking strength (2.22 MPa). The porosity of the SF-gelatin layer was 87% and the pore diameter was 142 nm. After 12 days of cultivation, SEM observation demonstrated the scaffold was nontoxic, biocompatible, and capable of supporting 3T3 mouse fibroblasts attachment, spreading, and growth. The hemolysis test proved the scaffolds with hemolytic rates from 3.1 to 4.5%. The subcutaneous implantation test indicated minor inflammatory reactions surrounding the scaffolds and biodegradation were initially observed in about 3 months. The desired porous structure, strong and pliable properties, combined with the ability of PLA/SF-gelatin scaffold to support cell growth in vitro, especially excellent biocompatibility in vivo, suggested potential application for tissue engineering scaffolds.
机译:本文通过多层静电纺丝制备了聚L-乳酸(PLA)/丝素蛋白(SF)-明胶的纳米纤维复合支架。为了研究PLA / SF-明胶用作支架的可行性,检查了孔隙率和机械性能。尤其是,根据ISO 10993的要求,通过细胞粘附和细胞毒性测试,短期皮下植入测试和急性溶血测试对体内和体外的生物相容性进行了评估。结果表明,支架达到了理想的水平柔韧性(弹性高达7.3%应变)和适当的断裂强度(2.22 MPa)。 SF-明胶层的孔隙率为87%,孔径为142nm。培养12天后,SEM观察表明该支架是无毒的,生物相容的,并能够支持3T3小鼠成纤维细胞的附着,扩散和生长。溶血试验证明支架的溶血率为3.1%至4.5%。皮下植入试验表明支架周围有轻微炎症反应,最初在约3个月内观察到生物降解。所需的多孔结构,坚固而柔韧的特性,再加上PLA / SF明胶支架在体外支持细胞生长的能力,尤其是体内优异的生物相容性,提示了组织工程支架的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号